Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Gigaxonin Suppresses Epithelial-to-Mesenchymal Transition of Human Cancer Through Downregulation of Snail.

Cancer research communications·2024
Same author

Liposomes as Carriers for the Delivery of Efavirenz in Combination with Glutathione-An Approach to Combat Opportunistic Infections.

Applied sciences (Basel, Switzerland)·2022
Same author

Topical Delivery of Carvedilol Loaded Nano-Transfersomes for Skin Cancer Chemoprevention.

Pharmaceutics·2020
Same author

Dysregulation of hsa-miR-34a and hsa-miR-449a leads to overexpression of PACS-1 and loss of DNA damage response (DDR) in cervical cancer.

The Journal of biological chemistry·2020
Same author

Formulation of Dronedarone Hydrochloride-Loaded Proliposomes: In Vitro and In Vivo Evaluation Using Caco-2 and Rat Model.

AAPS PharmSciTech·2019
Same author

Critical In Vitro Characterization Methods of Lipid-Based Formulations for Oral Delivery: a Comprehensive Review.

AAPS PharmSciTech·2018

Related Experiment Video

Updated: Dec 28, 2025

On-Chip Octanol-Assisted Liposome Assembly for Bioengineering
09:45

On-Chip Octanol-Assisted Liposome Assembly for Bioengineering

Published on: March 17, 2023

3.3K

Proliposomes for oral delivery: progress and challenges.

Vijaykumar Nekkanti, Natarajan Venkatesan, Guru V Betageri1

  • 1Graduate College of Biomedical Sciences, Western University of Health Sciences, 309 E. Second Street, Pomona, CA 91766, USA. gbetageri@westernu.edu.

Current Pharmaceutical Biotechnology
|January 21, 2015
PubMed
Summary
This summary is machine-generated.

Proliposomes, phospholipid-based drug carriers, enhance oral drug delivery for poorly bioavailable medications. Further research into their biological behavior is crucial for optimizing clinical applications.

More Related Videos

Microfluidic Production of Lysolipid-Containing Temperature-Sensitive Liposomes
09:51

Microfluidic Production of Lysolipid-Containing Temperature-Sensitive Liposomes

Published on: March 3, 2020

9.6K
Preparation and Characterization of Nanoliposomes for the Entrapment of Bioactive Hydrophilic Globular Proteins
11:30

Preparation and Characterization of Nanoliposomes for the Entrapment of Bioactive Hydrophilic Globular Proteins

Published on: August 31, 2019

25.0K

Related Experiment Videos

Last Updated: Dec 28, 2025

On-Chip Octanol-Assisted Liposome Assembly for Bioengineering
09:45

On-Chip Octanol-Assisted Liposome Assembly for Bioengineering

Published on: March 17, 2023

3.3K
Microfluidic Production of Lysolipid-Containing Temperature-Sensitive Liposomes
09:51

Microfluidic Production of Lysolipid-Containing Temperature-Sensitive Liposomes

Published on: March 3, 2020

9.6K
Preparation and Characterization of Nanoliposomes for the Entrapment of Bioactive Hydrophilic Globular Proteins
11:30

Preparation and Characterization of Nanoliposomes for the Entrapment of Bioactive Hydrophilic Globular Proteins

Published on: August 31, 2019

25.0K

Area of Science:

  • Pharmaceutics
  • Drug Delivery Systems
  • Biotechnology

Background:

  • Proliposomes are phospholipid-based systems utilized in drug delivery.
  • They show promise for oral administration of drugs with low bioavailability.
  • Understanding their absorption and cellular uptake mechanisms is currently limited.

Purpose of the Study:

  • To review the current state of proliposomal drug delivery.
  • To summarize the efficacy of proliposomes in oral drug delivery.
  • To identify key areas for future research to ensure clinical viability.

Main Methods:

  • Literature review of proliposomal drug delivery systems.
  • Analysis of studies focusing on oral delivery of drugs with poor bioavailability.
  • Evaluation of proliposomes' physical and biological behavior.

Main Results:

  • Proliposomes are effective in improving the bioavailability of certain drugs.
  • Reformulation with proliposomes can enhance therapeutic indices by altering drug uptake.
  • Established platform technology with growing clinical acceptance.

Conclusions:

  • Further investigation into proliposome absorption and cellular uptake is essential.
  • A comprehensive understanding of their behavior in biological environments is needed.
  • Proliposomes represent a promising approach for improving drug delivery and therapeutic outcomes.